(Q36934286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Anthony W Tolcher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Alain Mita

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Lionel D Lewis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Christopher R Garrett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Elizabeth Till

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Amita Patnaik

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Kyri Papadopoulos

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Chris Takimoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Pamela Bartels

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Anne Keating

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Scott Antonia

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

29 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

5198-5203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters.

14 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

Solution structure of human survivin and its binding interface with Smac/Diablo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

An IAP-IAP complex inhibits apoptosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

Survivin, cancer networks and pathway-directed drug discovery.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

Expression of the NF-κB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4879696

Survivin is an independent prognostic marker for risk stratification of breast cancer patients

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18824702

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18824702

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18824702

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2008.17.2064

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18824702%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference